Canon Medical's AI Imaging Innovation Achieves Regulatory Clearance
Tustin, Friday, 14 March 2025.
Canon Medical Systems’ AI-enhanced imaging technology, Aquilion ONE, secured regulatory clearance, promising faster, more accurate diagnostics, and revolutionizing healthcare imaging efficiency.
Revolutionary AI-Enhanced Imaging Technology
Canon Medical Systems has achieved a significant breakthrough with their latest AI enhancement for the Aquilion ONE / INSIGHT Edition, featuring the innovative PIQE 1024 matrix and SilverBeam technology [1]. The system’s excellence has already garnered industry recognition, securing the prestigious 2024 Best New Radiology Device award at the Minnies Awards in November 2024 [1].
Advanced Technical Capabilities
The system’s Precise IQ Engine (PIQE), powered by Canon Medical’s AI brand Altivity, represents a significant advancement in medical imaging. This Deep Learning Reconstruction (DLR) technology enables 1024 matrix CT imaging while maintaining exceptional resolution without increasing radiation exposure [1]. The SilverBeam Filter technology has expanded its applications beyond lung cancer screening to include musculoskeletal (MSK) imaging, utilizing silver’s unique photon-attenuating properties to deliver unprecedented clarity at ultra-low doses [1].
Impact on Healthcare Delivery
Operating from their headquarters in Tustin, California, Canon Medical Systems continues to expand their comprehensive suite of diagnostic medical imaging solutions [1]. The company’s commitment to healthcare advancement is evident in their extensive portfolio, which includes CT, X-Ray, Ultrasound, Vascular and MR technologies, alongside integrated Healthcare IT solutions [1]. This latest clearance aligns with Canon Medical’s mission to enhance patient care through technological innovation, as emphasized by Satrajit Misra, Chief Sales and Marketing Officer of Canon Medical Systems USA [1].
Future Implications
This regulatory clearance marks a significant milestone in Canon Medical’s ongoing commitment to advancing healthcare technology [1]. The company’s approach to building transparent partnerships with medical, academic, and research communities [1] positions them to continue delivering innovations that prioritize patient comfort, safety, and optimal health outcomes [GPT].